The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 2 August 2004. doi:10.1084/jem.20040370
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 200, Number 3, 287-295
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 844K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Granucci, F.
Right arrow Articles by Ricciardi-Castagnoli, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Granucci, F.
Right arrow Articles by Ricciardi-Castagnoli, P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
A Contribution of Mouse Dendritic Cell–Derived IL-2 for NK Cell Activation

Francesca Granucci1, Ivan Zanoni1, Norman Pavelka1, Serani L.H. van Dommelen2, Christopher E. Andoniou2, Filippo Belardelli3, Mariapia A. Degli Esposti2, and Paola Ricciardi-Castagnoli1

1 Department of Biotechnology and Bioscience, University of Milano-Bicocca, 20126 Milan, Italy
2 Immunology and Virology Program, Centre for Ophthalmology and Visual Sciences, The University of Western Australia and Centre for Experimental Immunology, Lions Eye Institute, Perth 6009, Western Australia, Australia
3 Laboratory of Virology, Istituto Superiore di Sanità, 00100 Rome, Italy

Address correspondence to Paola Ricciardi-Castagnoli, Dept. of Biotechnology and Bioscience, University of Milano–Bicocca Piazza della Scienza, 2, 20126 Milano, Italy. Phone: 39-02-64483559; Fax: 39-02-64483552; email: paola.castagnoli{at}unimib.it

Dendritic cells (DCs) play a predominant role in activation of natural killer (NK) cells that exert their functions against pathogen-infected and tumor cells. Here, we used a murine model to investigate the molecular mechanisms responsible for this process. Two soluble molecules produced by bacterially activated myeloid DCs are required for optimal priming of NK cells. Type I interferons (IFNs) promote the cytotoxic functions of NK cells. IL-2 is necessary both in vitro and in vivo for the efficient production of IFN{gamma}, which has an important antimetastatic and antibacterial function. These findings provide new information about the mechanisms that mediate DC–NK cell interactions and define a novel and fundamental role for IL-2 in innate immunity.

Key Words: NK cells • dendritic cells • innate immune response • interleukin 2 • interferon {gamma}

F. Granucci and I. Zanoni contributed equally to this work.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS